Play (<1min) CharlieAJA/iStock via Getty Images Bionano Genomics (NASDAQ: BNGO) shares jumped in post market trading on Wednesday after it reported its first-quarter revenue above expectations.

SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2025. “The first quarter of 2025 ...

SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2025. “The first quarter of 2025 ...

Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2024 Earnings Call Transcript March 31, 2025 Bionano Genomics, Inc. reports earnings inline with expectations. Reported EPS is $-5.898 EPS, expectations ...

Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2024 Earnings Call Transcript March 31, 2025Bionano Genomics, Inc. reports earnings inline with expectations.

Bionano Genomics (BNGO -0.88%) Q4 2024 Earnings Call Mar 31, 2025, 4:30 p.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good day, and welcome ...

Image source: The Motley Fool. Bionano Genomics (NASDAQ: BNGO) Q4 2024 Earnings Call Mar 31, 2025, 4:30 p.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks ...

Bionano Genomics is also focusing on the adoption of its VIA software and is planning for the full rollout of the Ionic sample prep system in 2024.

Good day, and welcome to the Bionano third quarter 2024 earnings conference call. Today's conference is being recorded. At this time, I would like to turn the conference over to David Holmes from ...